A new spinoff company is about to launch a computer model that aims to accelerate process development by speeding up the optimization of cell culture media. AuctuCel, which plans to open for business ...

TOKYO & MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and ...